Applied Clinical Trials
Applied Clinical Trials-06-01-2025
Volume: 34
Issue: 3
Applied Clinical Trials-04-01-2025
Volume: 34
Issue: 2
Applied Clinical Trials-02-01-2025
Volume: 34
Issue: 1
Applied Clinical Trials-12-01-2024
Volume: 33
Issue: 12
Applied Clinical Trials-11-01-2024
Volume: 33
Issue: 11
Applied Clinical Trials-10-01-2024
Volume: 33
Issue: 10
Applied Clinical Trials-09-01-2024
Volume: 33
Issue: 9
Applied Clinical Trials-08-01-2024
Volume: 33
Issue: 8
Applied Clinical Trials-06-01-2024
Volume: 33
Issue: 6
Applied Clinical Trials-05-01-2024
Volume: 33
Issue: 5
Applied Clinical Trials-04-01-2024
Volume: 33
Issue: 4
Applied Clinical Trials-03-01-2024
Volume: 33
Issue: 3
Applied Clinical Trials-02-01-2024
Volume: 33
Issue: 1/2
Applied Clinical Trials-12-01-2023
Volume: 32
Issue: 12
Applied Clinical Trials-11-01-2023
Volume: 32
Issue: 11
Applied Clinical Trials-10-01-2023
Volume: 32
Issue: 10
Applied Clinical Trials-09-01-2023
Volume: 32
Issue: 9
Applied Clinical Trials-08-01-2023
Volume: 32
Issue: 7/8
Applied Clinical Trials-06-01-2023
Volume: 32
Issue: 6
Applied Clinical Trials-05-01-2023
Volume: 32
Issue: 5
Applied Clinical Trials-04-01-2023
Volume: 32
Issue: 4
Applied Clinical Trials-03-01-2023
Volume: 32
Issue: 3
Applied Clinical Trials-02-01-2023
Volume: 32
Issue: 1/2
Applied Clinical Trials-12-01-2022
Volume: 31
Issue: 12
Applied Clinical Trials-11-01-2022
Volume: 31
Issue: 11
Applied Clinical Trials-10-01-2022
Volume: 31
Issue: 10
Applied Clinical Trials-09-01-2022
Volume: 31
Issue: 9
Applied Clinical Trials-08-01-2022
Volume: 31
Issue: 7/8
Applied Clinical Trials-06-01-2022
Volume: 31
Issue: 6
Applied Clinical Trials-05-01-2022
Volume: 31
Issue: 5
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
